Clinical Trial Update: Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

View source ↗

Summary

The clinical trial investigating the occurrence of HPA-1a alloimmunization in women at high risk for fetal and neonatal alloimmune thrombocytopenia has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal and Neonatal Alloimmune Thrombocytopenia

Snippet

Sponsor: Rallybio | Conditions: Fetal and Neonatal Alloimmune Thrombocytopenia | Status: COMPLETED